ARWR vs CRM · rev $829.4M vs P/E 41, rev $11.35B
Arrowhead Pharmaceuticals Inc (ARWR) versus Salesforce.com Inc (CRM) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Salesforce.com Inc (CRM) is a software - application company listed on US. It is led by Marc R. Benioff.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported CRM revenue for 2026-07-31 was $11.35B. Net income was $3.53B. Revenue was up 1.9% from 2026-04-30 to 2026-07-31. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
ARWR currently screens at market cap $10.59B. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
Not investment advice. Open the ARWR and CRM stock pages for the full models.
Not investment advice.